Technical Analysis for SYRE - Spyre Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 27.50 | 2.23% | 0.60 |
SYRE closed up 2.23 percent on Wednesday, November 20, 2024, on 2.12 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 2.23% | |
| Volume Surge | Other | 2.23% | |
| Calm After Storm | Range Contraction | 2.23% | |
| Lower Bollinger Band Walk | Weakness | 2.23% |
| Alert | Time |
|---|---|
| Possible NR7 | about 18 hours ago |
| Up 5% | about 19 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
| Up 3% | about 19 hours ago |
| Up 2% | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Autoimmune Disease Antibodies Monoclonal Antibody Antibody Inflammatory Bowel Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Autoimmune Disease Antibodies Monoclonal Antibody Antibody Inflammatory Bowel Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.97 |
| 52 Week Low | 10.42 |
| Average Volume | 588,585 |
| 200-Day Moving Average | 31.26 |
| 50-Day Moving Average | 31.28 |
| 20-Day Moving Average | 33.74 |
| 10-Day Moving Average | 32.90 |
| Average True Range | 2.40 |
| RSI (14) | 35.06 |
| ADX | 30.01 |
| +DI | 16.00 |
| -DI | 40.20 |
| Chandelier Exit (Long, 3 ATRs) | 33.05 |
| Chandelier Exit (Short, 3 ATRs) | 32.95 |
| Upper Bollinger Bands | 40.79 |
| Lower Bollinger Band | 26.70 |
| Percent B (%b) | 0.06 |
| BandWidth | 41.75 |
| MACD Line | -0.74 |
| MACD Signal Line | 0.54 |
| MACD Histogram | -1.282 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 30.01 | ||||
| Resistance 3 (R3) | 30.05 | 29.27 | 29.59 | ||
| Resistance 2 (R2) | 29.27 | 28.63 | 29.24 | 29.45 | |
| Resistance 1 (R1) | 28.38 | 28.23 | 28.83 | 28.34 | 29.31 |
| Pivot Point | 27.60 | 27.60 | 27.82 | 27.57 | 27.60 |
| Support 1 (S1) | 26.71 | 26.96 | 27.16 | 26.67 | 25.69 |
| Support 2 (S2) | 25.93 | 26.56 | 25.90 | 25.55 | |
| Support 3 (S3) | 25.04 | 25.93 | 25.41 | ||
| Support 4 (S4) | 25.00 |
